Literature DB >> 25183263

DMPA and HIV: why we need a trial.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25183263     DOI： 10.1016/j.contraception.2014.08.007

Source DB:  PubMed          Journal:  Contraception        ISSN： 0010-7824            Impact factor:   3.375


× No keyword cloud information.
  8 in total

Review 1.  Implementation Research for the Prevention of Mother-to-Child HIV Transmission in Sub-Saharan Africa: Existing Evidence, Current Gaps, and New Opportunities.

Authors:  Sanjana Bhardwaj; Bryan Carter; Gregory A Aarons; Benjamin H Chi
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

2.  A Depot Medroxyprogesterone Acetate Dose That Models Human Use and Its Effect on Vaginal SHIV Acquisition Risk.

Authors:  Katherine Butler; Jana M Ritter; Shanon Ellis; Monica R Morris; Debra L Hanson; Janet M McNicholl; Ellen N Kersh
Journal:  J Acquir Immune Defic Syndr       Date:  2016-08-01       Impact factor: 3.731

3.  Hormonal contraception does not increase women's HIV acquisition risk in Zambian discordant couples, 1994-2012.

Authors:  Kristin M Wall; William Kilembe; Bellington Vwalika; Naw Htee Khu; Ilene Brill; Elwyn Chomba; Brent A Johnson; Lisa Haddad; Amanda Tichacek; Susan Allen
Journal:  Contraception       Date:  2015-02-21       Impact factor: 3.375

4.  Broadening the debate over HIV and hormonal contraception.

Authors:  Christopher J Colvin; Abigail Harrison
Journal:  Lancet Infect Dis       Date:  2015-01-09       Impact factor: 25.071

5.  Medroxyprogesterone Acetate (MPA) Enhances HIV-1 Accumulation and Release in Primary Cervical Epithelial Cells by Inhibiting Lysosomal Activity.

Authors:  Xiangxu Jia; Qiujia Shao; Ahsen R Chaudhry; Ballington L Kinlock; Michael G Izban; Hong-Ying Zhang; Fernando Villalta; James E K Hildreth; Bindong Liu
Journal:  Pathogens       Date:  2021-09-14

6.  Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.

Authors:  Charles S Morrison; Pai-Lien Chen; Cynthia Kwok; Jared M Baeten; Joelle Brown; Angela M Crook; Lut Van Damme; Sinead Delany-Moretlwe; Suzanna C Francis; Barbara A Friedland; Richard J Hayes; Renee Heffron; Saidi Kapiga; Quarraisha Abdool Karim; Stephanie Karpoff; Rupert Kaul; R Scott McClelland; Sheena McCormack; Nuala McGrath; Landon Myer; Helen Rees; Ariane van der Straten; Deborah Watson-Jones; Janneke H H M van de Wijgert; Randy Stalter; Nicola Low
Journal:  PLoS Med       Date:  2015-01-22       Impact factor: 11.069

7.  Rationale and design of a multi-center, open-label, randomised clinical trial comparing HIV incidence and contraceptive benefits in women using three commonly-used contraceptive methods (the ECHO study).

Authors:  G Justus Hofmeyr; Charles S Morrison; Jared M Baeten; Tsungai Chipato; Deborah Donnell; Peter Gichangi; Nelly Mugo; Kavita Nanda; Helen Rees; Petrus Steyn; Douglas Taylor
Journal:  Gates Open Res       Date:  2018-03-13

8.  Is the Injectable Contraceptive Depo-Medroxyprogesterone Acetate (DMPA-IM) Associated with an Increased Risk for HIV Acquisition? The Jury Is Still Out.

Authors:  Janet P Hapgood
Journal:  AIDS Res Hum Retroviruses       Date:  2020-01-22       Impact factor: 2.205
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.